Clinical trial
The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
NCT03797001 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Interleukin-1 Blockade On Exercise Capacity In Patients With Recently Decompensated Systolic Heart Failure
- Lead sponsor
- Virginia Commonwealth University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 4, 2019
- Completion date
- July 22, 2024
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.